|
1
|
Du Z, Sun T, Hacisuleyman E, Fei T, Wang
X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW and Liu XS:
Integrative analyses reveal a long noncoding RNA-mediated sponge
regulatory network in prostate cancer. Nat Commun. 7:109822016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Song YX and Wang ZN: Non-coding
RNAs in gastric cancer. Gene. 560:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang F, Ying HQ, He BS, Pan YQ, Deng QW,
Sun HL, Chen J, Liu X and Wang SK: Upregulated lncRNA-UCA1
contributes to progression of hepatocellular carcinoma through
inhibition of miR-216b and activation of FGFR1/ERK signaling
pathway. Oncotarget. 6:7899–7917. 2015.PubMed/NCBI
|
|
4
|
Iguchi T, Uchi R, Nambara S, Saito T,
Komatsu H, Hirata H, Ueda M, Sakimura S, Takano Y, Kurashige J, et
al: A long noncoding RNA, lncRNA-ATB, is involved in the
progression and prognosis of colorectal cancer. Anticancer Res.
35:1385–1388. 2015.PubMed/NCBI
|
|
5
|
Liu Y, Zhang M, Liang L, Li J and Chen YX:
Over-expression of lncRNA DANCR is associated with advanced tumor
progression and poor prognosis in patients with colorectal cancer.
Int J Clin Exp Pathol. 8:11480–11484. 2015.PubMed/NCBI
|
|
6
|
Cui Y, Zhang F, Zhu C, Geng L, Tian T and
Liu H: Upregulated lncRNA SNHG1 contributes to progression of
non-small cell lung cancer through inhibition of miR-101-3p and
activation of Wnt/β-catenin signaling pathway. Oncotarget.
8:17785–17794. 2017.PubMed/NCBI
|
|
7
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A,
Lu Z, Wu F and Mo YY: LncRNA loc285194 is a p53-regulated tumor
suppressor. Nucleic Acids Res. 41:4976–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi XF, Sun M, Liu HB, Yao YW and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hauptman N and Glavač D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang H, Chen Z, Wang X, Huang Z, He Z and
Chen Y: Long non-coding RNA: A new player in cancer. J Hematol
Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Neumann P, Jaé N, Knau A, Glaser SF,
Fouani Y, Rossbach O, Krüger M, John D, Bindereif A, Grote P, et
al: The lncRNA GATA6-AS epigenetically regulates endothelial gene
expression via interaction with LOXL2. Nature Commun. 9:2372018.
View Article : Google Scholar
|
|
13
|
Wang S, Liang K, Hu Q, Li P, Song J, Yang
Y, Yao J, Mangala LS, Li C, Yang W, et al: JAK2-binding long
noncoding RNA promotes breast cancer brain metastasis. J Clin
Invest. 127:4498–4515. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li C, Li W, Zhang Y, Zhang X, Liu T, Zhang
Y, Yang Y, Wang L, Pan H, Ji J and Wang C: Increased expression of
antisense lncrna SPINT1-AS1 predicts a poor prognosis in colorectal
cancer and is negatively correlated with its sense transcript. Onco
Targets Ther. 11:3969–3978. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang E, Li W, Yin D, De W, Zhu L, Sun S
and Han L: c-Myc-regulated long non-coding RNA H19 indicates a poor
prognosis and affects cell proliferation in non-small-cell lung
cancer. Tumor Biol. 37:4007–4015. 2016. View Article : Google Scholar
|
|
16
|
Sostres C, Gargallo CJ and Lanas A:
Aspirin, cyclooxygenase inhibition and colorectal cancer. World
World J Gastrointest Pharmacol Ther. 5:40–49. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marley AR and Nan H: Epidemiology of
colorectal cancer. Int J Mol Epidemiol Genet. 7:105–114.
2016.PubMed/NCBI
|
|
18
|
Ma S, Yang D, Liu Y, Wang Y, Lin T, Li Y,
Yang S, Zhang W and Zhang R: LncRNA BANCR promotes tumorigenesis
and enhances adriamycin resistance in colorectal cancer. Aging
(Albany NY). 10:2062–2078. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li G, Wang C, Wang Y, Xu B and Zhang W:
LINC 00312 represses proliferation and metastasis of colorectal
cancer cells by regulation of miR-21. J Cell Mol Med. 22:5565–5572.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang K, Liu J, Li C, Peng X, Li H and Li
Z: Identification and validation of potential target genes in
papillary thyroid cancer. Eur J Pharmacol. 843:217–225. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan W, Li X, Liu L, Wei C, Sun D, Peng S
and Jiang L: Comprehensive analysis of lncRNA-associated ceRNA
network in colorectal cancer. Biochem Biophys Res Commun.
508:374–379. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miao Y, Sui J, Xu SY, Liang GY, Pu YP and
Yin LH: Comprehensive analysis of a novel four-lncRNA signature as
a prognostic biomarker for human gastric cancer. Oncotarget.
8:75007–75024. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang S, Ke H, Zhang H, Ma Y, Ao L, Zou L,
Yang Q, Zhu H, Nie J, Wu C and Jiao B: LncRNA MIR100HG promotes
cell proliferation in triple-negative breast cancer through triplex
formation with p27 loci. Cell Death Dis. 9:8052018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang X, Li M, Wang Z, Han S, Tang X, Ge Y,
Zhou L, Zhou C, Yuan Q and Yang M: Silencing of long noncoding RNA
MALAT1 by miR-101 and miR-217 inhibits proliferation, migration,
and invasion of esophageal squamous cell carcinoma cells. J Biol
Chem. 290:3925–3935. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cao Q, Wang N, Qi J, Gu Z and Shen HJ:
Long non-coding RNA-GAS5 acts as a tumor suppressor in bladder
transitional cell carcinoma via regulation of chemokine (C-C motif)
ligand 1 expression. Mol Med Rep. 13:27–34. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsukamoto S, Ishikawa T, Iida S, Ishiguro
M, Mogushi K, Mizushima H, Uetake H, Tanaka H and Sugihara K:
Clinical significance of osteoprotegerin expression in human
colorectal cancer. Clin Cancer Res. 17:2444–2450. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Binefa G, Rodríguez-Moranta F, Teule A and
Medina-Hayas M: Colorectal cancer: From prevention to personalized
medicine. World J Gastroenterol. 20:6786–6808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
R Core Team, . R: A language and
environment for statistical computingR Foundation for Statistical
Computing; Vienna, Austria: 2013
|
|
30
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Golubeva Y and Rogers K: Collection and
preparation of rodent tissue samples for histopathological and
molecular studies in carcinogenesis. Methods Mol Biol. 511:3–60.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Graham LD, Pedersen SK, Brown GS, Ho T,
Kassir Z, Moynihan AT, Vizgoft EK, Dunne R, Pimlott L, Young GP, et
al: Colorectal neoplasia differentially expressed (CRNDE), a novel
gene with elevated expression in colorectal adenomas and
adenocarcinomas. Genes Cancer. 2:829–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mourtada-Maarabouni M, Hedge VL, Kirkham
L, Farzaneh F and Williams GT: Growth arrest in human T-cells is
controlled by the non-coding RNA growth-arrest-specific transcript
5 (GAS5). J Cell Sci. 121:939–946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H, Zhou D, Ying M, Chen M, Chen P,
Chen Z and Zhang F: Expression of long non-coding RNA (lncRNA)
small nucleolar RNA Host Gene 1 (SNHG1) exacerbates hepatocellular
carcinoma through suppressing miR-195. Med Sci Monit. 22:4820–4829.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ying Z, Sun L, Xuan L, Pan Z, Li K, Liu S,
Huang Y, Zhao X, Huang L, Wang Z, et al: Reciprocal changes of
circulating long non-coding RNAs ZFAS1 and CDR1AS predict acute
myocardial infarction. Sci Rep. 6:223842016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao Y, Qin ZS, Feng Y, Tang XJ, Zhang T
and Yang L: Long non-coding RNA (lncRNA) small nucleolar RNA host
gene 1 (SNHG1) promote cell proliferation in colorectal cancer by
affecting P53. Eur Rev Med Pharmacol Sci. 22:976–984.
2018.PubMed/NCBI
|
|
37
|
Xie S, Ge Q, Wang X, Sun X and Kang Y:
Long non-coding RNA ZFAS1 sponges miR-484 to promote cell
proliferation and invasion in colorectal cancer. Cell Cycle.
17:154–161. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu F, Gao H, Li S, Ni X and Zhu Z: Long
non-coding RNA ZFAS1 correlates with clinical progression and
prognosis in cancer patients. Oncotarget. 8:61561–61569.
2017.PubMed/NCBI
|
|
39
|
Budczies J, Klauschen F, Sinn BV, Győrffy
B, Schmitt WD, Darb-Esfahani S and Denkert C: Cutoff finder: A
Comprehensive and straightforward web application enabling rapid
biomarker cutoff optimization. PLoS One. 7:e518622012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li M, Bian Z, Yao S, Zhang J, Jin G, Wang
X, Yin Y and Huang Z: Up-regulated expression of SNHG6 predicts
poor prognosis in colorectal cancer. Pathol Res Pract. 214:784–789.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu T, Han Z, Li H, Zhu Y, Sun Z and Zhu
A: LncRNA DLEU1 contributes to colorectal cancer progression via
activation of KPNA3. Mol Cancer. 17:1182018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou J, Lin J, Zhang H, Zhu F and Xie R:
LncRNA HAND2-AS1 sponging miR-1275 suppresses colorectal cancer
progression by upregulating KLF14. Biochem Biophys Res Commun.
503:1848–1853. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ding J, Li J, Wang H, Tian Y, Xie M, He X,
Ji H, Ma Z, Hui B, Wang K and Ji G: Long noncoding RNA CRNDE
promotes colorectal cancer cell proliferation via epigenetically
silencing DUSP5/CDKN1A expression. Cell Death Dis. 8:e29972017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cheng K, Zhao Z, Wang G, Wang J and Zhu W:
lncRNA GAS5 inhibits colorectal cancer cell proliferation via the
miR-182-5p/FOXO3a axis. Oncol Rep. 40:2371–2380. 2018.PubMed/NCBI
|
|
45
|
Tian T, Qiu R and Qiu X: SNHG1 promotes
cell proliferation by acting as a sponge of miR-145 in colorectal
cancer. Oncotarget. 9:2128–2139. 2017.PubMed/NCBI
|
|
46
|
Wang P, Fu H, Cui J and Chen X:
Differential lncRNA-mRNA co-expression network analysis revealing
the potential regulatory roles of lncRNAs in myocardial infarction.
Mol Med Rep. 13:1195–1203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Egede LE and Zheng D: Independent factors
associated with major depressive disorder in a national sample of
individuals with diabetes. Diabetes Care. 26:104–111. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jin P, Wang J and Liu Y: Downregulation of
a novel long non-coding RNA, LOC389332, is associated with poor
prognosis and tumor progression in clear cell renal cell carcinoma.
Exp Ther Med. 13:1137–1142. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xu S, Wang P, You Z, Meng H, Mu G, Bai X,
Zhang G, Zhang J and Pang D: The long non-coding RNA EPB41L4A-AS2
inhibits tumor proliferation and is associated with favorable
prognoses in breast cancer and other solid tumors. Oncotarget.
7:20704–20717. 2016.PubMed/NCBI
|
|
50
|
Alterio J, Masson J, Diaz J, Chachlaki K,
Salman H, Areias J, Al Awabdh S, Emerit MB and Darmon M: Yif1B is
involved in the Anterograde traffic pathway and the Golgi
Architecture. Traffic. 16:978–993. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang L, Wildt KF, Castro E, Xiong Y,
Feigenbaum L, Tessarollo L and Bosselut R: The zinc finger
transcription factor Zbtb7b represses CD8-lineage gene expression
in peripheral CD4+ T cells. Immunity. 29:876–887. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jung Y, Yong S, Kim P, Lee HY, Jung Y,
Keum J, Lee S and Kim J and Kim J: VAMP2-NRG1 fusion gene is a
novel oncogenic driver of non-small-cell lung adenocarcinoma. J
Thorac Oncol. 10:1107–1111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Scaggiante B, Dapas B, Bonin S, Grassi M,
Zennaro C, Farra R, Cristiano L, Siracusano S, Zanconati F,
Giansante C and Grassi G: Dissecting the expression of EEF1A1/2
genes in human prostate cancer cells: The potential of EEF1A2 as a
hallmark for prostate transformation and progression. Br J Cancer.
106:166–173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Visconti R, Della Monica R and Grieco D:
Cell cycle checkpoint in cancer: A therapeutically targetable
double-edged sword. J Exp Clin Cancer Res. 35:1532016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Buczacki SJA, Popova S, Biggs E, Koukorava
C, Buzzelli J, Vermeulen L, Hazelwood L, Francies H, Garnett MJ and
Winton DJ: Itraconazole targets cell cycle heterogeneity in
colorectal cancer. J Exp Med. 215:1891–1912. 2018.PubMed/NCBI
|
|
57
|
Baan B, Dihal AA, Hoff E, Bos CL,
Voorneveld PW, Koelink PJ, Wildenberg ME, Muncan V, Heijmans J,
Verspaget HW, et al: 5-Aminosalicylic acid inhibits cell cycle
progression in a phospholipase D dependent manner in colorectal
cancer. Gut. 61:1708–1715. 2012. View Article : Google Scholar : PubMed/NCBI
|
